Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Thermo Fisher Scientific Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-02), 10-Q (reporting date: 2021-07-03), 10-Q (reporting date: 2021-04-03), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-26), 10-Q (reporting date: 2020-06-27), 10-Q (reporting date: 2020-03-28).
- Short-term Obligations and Current Maturities
- The short-term obligations demonstrated significant volatility, with notable spikes in December 2020 and April 2023, reaching 2,628 million and 5,579 million USD respectively. Following these peaks, values fluctuated but generally exhibited a declining trend towards mid-2025.
- Accounts Payable
- Accounts payable showed moderate fluctuations over the observed periods, generally increasing from 1,599 million USD in March 2020 to a peak around 3,079 million USD in March 2025. The trend reflects a steady growth in short-term obligations to suppliers.
- Accrued Payroll and Employee Benefits
- Accrued payroll and employee benefits increased sharply from 755 million USD in March 2020 to a peak of 2,427 million USD in December 2020, followed by periods of fluctuation and a general downward trend leading into mid-2025 with values around 1,518 million USD.
- Contract Liabilities
- Contract liabilities rose steadily from 938 million USD in March 2020 to a high of approximately 2,852 million USD in March 2025. Despite minor fluctuations, the overall trend shows an increasing balance of deferred revenue or prepayments received.
- Other Accrued Expenses
- Other accrued expenses displayed a generally rising trend, growing from 1,470 million USD in March 2020 to a peak of 3,393 million USD in September 2024. Some fluctuation occurred in later periods but values remained elevated relative to the beginning of the timeline.
- Current Liabilities
- Current liabilities showed sharp increases notably in December 2020 and December 2022, reaching 10,304 million USD and 17,010 million USD respectively. After peaking, the figures declined and stabilized to around 12,718 million USD by June 2025.
- Deferred Income Taxes
- Deferred income taxes demonstrated a marked decreasing trend over the period. Starting from 2,137 million USD in early 2020, the balance steadily declined to 624 million USD by June 2025, indicating a reduction in temporary tax timing differences or asset valuations.
- Other Long-term Liabilities
- This item remained relatively stable with small fluctuations, hovering between approximately 3,200 million USD and 4,600 million USD throughout the periods, with no pronounced long-term trend.
- Long-term Obligations (Excluding Current Maturities)
- Long-term obligations experienced significant growth, particularly from the end of 2020 onward. The balances rose from 19,231 million USD in March 2020 to over 33,000 million USD by June 2025, reflecting increased borrowing or financing activities.
- Long-term Liabilities
- Long-term liabilities mirrored the pattern of long-term obligations, increasing steadily from 24,629 million USD in March 2020 to near 38,000 million USD by mid-2025. This suggests an overall growth in the company’s long-term financial commitments.
- Total Liabilities
- Total liabilities increased substantially during the timeline, especially after 2020, rising from about 30,129 million USD to a peak of 54,146 million USD in December 2021. Thereafter, total liabilities fluctuated but remained elevated, around 50,000 million USD approaching 2025.
- Redeemable Noncontrolling Interest
- Minor balances were noted for redeemable noncontrolling interests starting from late 2021, fluctuating around 100 to 130 million USD without any notable trend.
- Common Stock and Capital in Excess of Par Value
- Both common stock and capital in excess of par value increased gradually over the period with minor incremental changes, reflecting ongoing equity contributions or issuances. Common stock rose from 435 million USD to 444 million USD, and capital in excess of par value from 15,186 million USD to 18,232 million USD.
- Retained Earnings
- Retained earnings showed consistent growth throughout the periods, increasing from 22,791 million USD in early 2020 to over 55,902 million USD by the middle of 2025, indicating sustained profitability and reinvestment of earnings.
- Treasury Stock at Cost
- The cost of treasury stock steadily increased (in absolute terms, becoming more negative), from -6,765 million USD to a peak around -21,269 million USD, reflecting significant share repurchase activity over time.
- Accumulated Other Comprehensive Loss
- This account exhibited fluctuations but showed a slight increasing trend in losses from -3,088 million USD to about -2,797 million USD by mid-2025, with some variability reflecting unrealized gains or losses in comprehensive income components.
- Total Shareholders' Equity
- Total shareholders’ equity generally increased from 28,559 million USD to around 50,512 million USD by mid-2025, although some periods such as early 2023 showed declines likely due to treasury stock increases or other comprehensive loss effects.
- Noncontrolling Interests
- Noncontrolling interests declined over time, reaching slightly negative values by mid-2025, suggesting reduced minority ownership stakes or adjustments within consolidated subsidiaries.
- Total Equity
- Total equity closely followed the pattern of shareholders’ equity but showed slight variations due to noncontrolling interests. The overall trend was growth from about 28,559 million USD to over 50,476 million USD.
- Total Liabilities, Redeemable Noncontrolling Interest and Equity
- This total rose substantially from approximately 58,688 million USD in early 2020 to over 101,230 million USD by mid-2025, reflecting overall growth in the company’s balance sheet size through increases in both liabilities and equity.